Tumor-Infiltrating B- and T-Cell Repertoire in Pancreatic Cancer Associated With Host and Tumor Features
暂无分享,去创建一个
E. López de Maturana | S. Pineda | N. Malats | M. Sirota | K. Yu | Akshay Ravoor | I. Wood | Katharine Yu
[1] D. Berman,et al. Sexual dimorphism in outcomes of non-muscle invasive bladder cancer: a role of CD163+ M2 macrophages, B cells and PD-L1 immune checkpoint , 2021, bioRxiv.
[2] Kim-Anh Lê Cao,et al. Variable selection in microbiome compositional data analysis , 2020, NAR genomics and bioinformatics.
[3] N. Malats,et al. Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose–Response Relationships , 2020, Cancer Epidemiology, Biomarkers & Prevention.
[4] O. Britanova,et al. B cells, plasma cells and antibody repertoires in the tumour microenvironment , 2020, Nature Reviews Immunology.
[5] Jinming Yu,et al. Smoking history influences the prognostic value of peripheral naïve CD4+ T cells in advanced non-small cell lung cancer , 2019, Cancer Cell International.
[6] A. Largeot,et al. The B-Side of Cancer Immunity: The Underrated Tune , 2019, Cells.
[7] S. Pineda,et al. Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencing , 2019, Nature Communications.
[8] Brian Ruffell,et al. Macrophages as regulators of tumour immunity and immunotherapy , 2019, Nature Reviews Immunology.
[9] S. Tomita,et al. Clinical verification of the relationship between smoking and the immune microenvironment of breast cancer , 2019, Journal of Translational Medicine.
[10] Zheming Lu,et al. T cell receptor β‐chain repertoire analysis of tumor‐infiltrating lymphocytes in pancreatic cancer , 2018, Cancer science.
[11] Jie Lin,et al. Network‐based integration of mRNA and miRNA profiles reveals new target genes involved in pancreatic cancer , 2018, Molecular carcinogenesis.
[12] B. Nelson,et al. Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer , 2018, Clinical Cancer Research.
[13] E. Jaffee,et al. T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma. , 2018, JCI insight.
[14] Jérôme Galon,et al. Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment , 2018, Front. Immunol..
[15] S. Byers,et al. Curation of the Pancreatic Ductal Adenocarcinoma Subset of the Cancer Genome Atlas Is Essential for Accurate Conclusions about Survival-Related Molecular Mechanisms , 2018, Clinical Cancer Research.
[16] N. Malats,et al. Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives. , 2018, International journal of epidemiology.
[17] Steven J. M. Jones,et al. The Immune Landscape of Cancer , 2018, Immunity.
[18] Neus Martínez-Bosch,et al. Immune Evasion in Pancreatic Cancer: From Mechanisms to Therapy , 2018, Cancers.
[19] Steven J. M. Jones,et al. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. , 2017, Cancer cell.
[20] E. Amir,et al. HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer , 2018, British Journal of Cancer.
[21] A. Butte,et al. xCell: digitally portraying the tissue cellular heterogeneity landscape , 2017, bioRxiv.
[22] K. Jirström,et al. Prognostic impact of tumour-associated B cells and plasma cells in oesophageal and gastric adenocarcinoma. , 2016, Journal of gastrointestinal oncology.
[23] A. Maitra,et al. Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma , 2016, Scientific Reports.
[24] K. Jirström,et al. Prognostic impact of tumour‐infiltrating B cells and plasma cells in colorectal cancer , 2016, International journal of cancer.
[25] K. Jirström,et al. Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer , 2016, Journal of Ovarian Research.
[26] R. Gibbs,et al. Genomic analyses identify molecular subtypes of pancreatic cancer , 2016, Nature.
[27] N. Malats,et al. Reduced risk of pancreatic cancer associated with asthma and nasal allergies , 2015, Gut.
[28] Z. Cai,et al. Characteristics of Tumor Infiltrating Lymphocyte and Circulating Lymphocyte Repertoires in Pancreatic Cancer by the Sequencing of T Cell Receptors , 2015, Scientific Reports.
[29] G. Kempermann. Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. , 2015 .
[30] Jun S. Liu,et al. The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.
[31] Mikhail Shugay,et al. MiXCR: software for comprehensive adaptive immunity profiling , 2015, Nature Methods.
[32] M. Porta. Faculty Opinions recommendation of Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. , 2015 .
[33] J. Kench,et al. Whole genomes redefine the mutational landscape of pancreatic cancer , 2015, Nature.
[34] P. Maisonneuve,et al. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. , 2015, International journal of epidemiology.
[35] A. Miller,et al. Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[36] G. de los Campos,et al. Genome-Wide Regression and Prediction with the BGLR Statistical Package , 2014, Genetics.
[37] Benjamin D. Smith,et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.
[38] J. Nielsen,et al. Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics. , 2014, Molecular & cellular proteomics : MCP.
[39] M. Junttila,et al. Influence of tumour micro-environment heterogeneity on therapeutic response , 2013, Nature.
[40] C. Dinney,et al. Inhibition of Inducible Heat Shock Protein-70 (Hsp72) Enhances Bortezomib-Induced Cell Death in Human Bladder Cancer Cells , 2013, PloS one.
[41] L. Holmberg,et al. The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer. , 2013, Cancer letters.
[42] R. Rance,et al. Network properties derived from deep sequencing of human B-cell receptor repertoires delineate B-cell populations , 2013, Genome research.
[43] Y. Kanai,et al. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer , 2013, British Journal of Cancer.
[44] Jonathan B. Mitchem,et al. Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. , 2013, Cancer research.
[45] A. McKenna,et al. Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.
[46] T. Whiteside,et al. For Breast Cancer Prognosis, Immunoglobulin Kappa Chain Surfaces to the Top , 2012, Clinical Cancer Research.
[47] M. Karin,et al. Immunity, Inflammation, and Cancer , 2010, Cell.
[48] G. Wahba. An introduction to reproducing kernel hilbert spaces and why they are so useful , 2003 .
[49] Shigeki Sugano,et al. IFAC Proceedings Volumes (IFAC-PapersOnline) , 2010 .